The Comparative Effect of Pioglitazone and Metformin on Serum Osteoprotegerin, Adiponectin and Intercellular Adhesion Molecule Concentrations in Patients with Newly Diagnosed Type 2 Diabetes: a Randomized Clinical Trial

Conclusion: Remarkably, patients receiving pioglitazone revealed more significant reduction in inflammatory markers.[...]© Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals:Table of contents  |  Abstract  |  Full text

Source: Experimental and Clinical Endocrinology and Diabetes - January 21, 2015 Category: Endocrinology Authors: Esteghamati, A.Azizi, R.Ebadi, M.Noshad, S.Mousavizadeh, M.Afarideh, M.Nakhjavani, M. Tags: Article Source Type: research